PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM)

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Functional T Cell Reactivity to Melanocyte Antigens Is Lost during the Progression of Malignant Melanoma, but Is Restored by Immunization

(2021) Anna Przybyla et al.   Cancers

CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer

(2020) Shanping Shi et al.   AUTOIMMUNITY

The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients

(2020) Xiaofang Wang et al.   BMC CANCER

Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma

(2020) Mona Yazdani et al.   VACCINE

Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma

(2020) Mark R. Middleton et al.   CLINICAL CANCER RESEARCH

Prognostic value of B cells in cutaneous melanoma

(2019) Sara R. Selitsky et al.   Genome Medicine

Targeted agents and immunotherapies: optimizing outcomes in melanoma

(2017) Jason J. Luke et al.   Nature Reviews Clinical Oncology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models

(2017) Grammatiki Fotaki et al.   OncoImmunology

Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches

(2017) Jeff Kamta et al.   Frontiers in Oncology

Melanosomal formation of PMEL core amyloid is driven by aromatic residues

(2017) Jia Shee Hee et al.   Scientific Reports

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

(2016) Michael D. Iglesia et al.   JNCI-Journal of the National Cancer Institute

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

(2016) Michael D. Iglesia et al.   JNCI-Journal of the National Cancer Institute

Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8 + T-cell Response and Protects Mice from Melanoma

(2015) Zhijuan Qiu et al.   Cancer Immunology Research

BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells

(2013) L. Rochin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Twist2 is a valuable prognostic biomarker for colorectal cancer

(2013) Hao Yu   WORLD JOURNAL OF GASTROENTEROLOGY

The Melanosomal Protein PMEL17 as a Target for Antibody Drug Conjugate Therapy in Melanoma

(2012) Youjun Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma

(2012) Farhad Azimi et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety and Immunogenicity of Vaccination With MART-1 (26–35, 27L), gp100 (209–217, 210M), and Tyrosinase (368–376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma

(2012) Ahmad A. Tarhini et al.   JOURNAL OF IMMUNOTHERAPY

Cancer immunotherapy comes of age

(2011) Ira Mellman et al.   NATURE

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

(2009) L. A. Johnson et al.   BLOOD

PrognoScan: a new database for meta-analysis of the prognostic value of genes

(2009) Hideaki Mizuno et al.   BMC Medical Genomics

Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions

(2008) Bonnie E Gould Rothberg et al.   MODERN PATHOLOGY